Degas™ Receiver Cell Engineering
DegasTM Receiver Cell Engineering constructs utilize non-viral genetic modification of the AAVS1 safe harbor loci to introduce a targeted receiver sequence for single step and efficient down-stream modifications. DegasTM technology allows for the development of isogenic cell lines simplifying cellular engineering, enabling insertion of multiple genetic elements to be developed and screened efficiently and reliably. Progenitor’s DegasTM receiver cell technology significantly reduces cellular editing workflows while ensuring quality modified cellular outcomes.
Degas™ Stealth Immune-Compatible Cell Systems
DegasTM Stealth technology is a non-viral targeted vector, which disrupts the function of MHC-I while also inducing the DegasTM Receiver Cassette. DegasTM Stealth allows for the generation of immune compatible cell lines, enabling off-the-shelf therapies currently lacking in immunotherapy development. DegasTM Stealth cells can be used in tandem with Progenitor’s MonetTM functionalized cell systems to create and enable tools for development of next generation immunotherapy constructs and workflows.
Monet™ Functionalized Cell Systems
Progenitor’s MonetTM technology utilizes DegasTM modified isogenic cell lines to introduce genetic elements of interest such as CARs, FcRs, suicide genes and co-stimulatory factors in a single transfection. MonetTM technology coupled with DegasTM receiver allows for precise gene insertion and enables multiplexed genetic modifications. The MonetTM and DegasTM technologies allow for gene editing quality and efficiency superior to current cellular engineering approaches.
Van Gogh™ Footprint-Free Gene Editing
Progenitor’s Van GoghTM technology improves nuclease-based genetic engineering of immune cells by developing an efficient approach for removing unwanted selection cassette DNA. Van GoghTM is a novel ‘self-excising’ cassette that enables rapid, permanent removal of the selection cassette by brief treatment of cells with a small molecule that induces Cre/loxP-mediated DNA recombination without possible reinsertion of deleted elements found in current market techniques. This technology ensures new levels of safety in constructs for cell immunotherapy.
Dali™ Xenobiotic Ligand-Regulated Genetic Engineering
Progenitor’s DaliTM technology consists of several xenobiotic ligands, which activate self-excising cassettes when co-cultured with modified cell lines. The DaliTM small xenobiotic ligands enable Van GoghTM footprint free gene editing without inducing negative effects on the modified cell lines found to occur with current methods and produce new approaches for next generation cellular immunotherapy.
Cezanne™ Integrated Cell/Antibody Therapeutic Systems
CezanneTM couples current monoclonal antibody therapeutics with the emerging cell therapy technologies by introducing engineered antibodies that specifically and uniquely pair with MonetTM modified cell lines eliminating innate molecule competition and reducing dose requirements. Progenitor’s revolutionary CezanneTM technology allows cellular therapies to more efficiently target solid tumors, as well as, hematological malignancies.